Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM)

20260 citationsJournal Articlegold Open Access

Authors

Sara López-Tarruella · Hospital General Universitario Gregorio Marañón

Ángel Guerrero-Zotano · Fundación Instituto Valenciano de Oncología

Silvia Antolín · Complexo Hospitalario Universitario A Coruña

Josefina Cruz · Hospital Universitario de Canarias

P. Martinez · Hospital de Basurto

Cesar Rodriguez · Instituto de Investigación Biomédica de Salamanca

Catalina Falo

Abstract

TN and HER2+ BC subtypes progressed faster to BCBM and had worse outcomes. Survival differed significantly between the two cohorts, BCBM1 and BCBM2. Continued research is essential to improve the treatment and prevention strategies.

Topics & Keywords

Brain Metastases and Treatment Advanced Breast Cancer Therapies Lung Cancer Research Studies

Publication Details

Published in: Therapeutic Advances in Medical Oncology

Volume 18, pp. 17588359261421813-17588359261421813

DOI: 10.1177/17588359261421813

Field-Weighted Citation Impact: 0.00

Command Palette

Clinical subtypes in breast cancer patients with brain metastases from an ambispective registry of advanced breast cancer, GEICAM/2014-03 (RegistEM)

Authors

Abstract

Topics & Keywords

Publication Details